NCT04897594View on ClinicalTrials.gov

AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic Steatohepatitis

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

May 20, 2021

Primary Completion Date

September 2, 2022

Study Completion Date

September 2, 2022

Conditions
NASH - Nonalcoholic Steatohepatitis
Interventions
DRUG

TERN-201

Investigational drug

OTHER

Placebo

Matching placebo

Trial Locations (11)

71220

Terns Clinical Study Site 1010, Bastrop

78215

Terns Clinical Study Site 1006, San Antonio

78229

Terns Clinical Study Site 1003, San Antonio

Terns Clinical Study Site 1019, San Antonio

85712

Terns Clinical Study Site 1018, Tucson

Terns Clinical Study Site 1024, Tucson

90048

Terns Clinical Study Site 1039, Los Angeles

91402

Terns Clinical Study Site 1001, Panorama City

92093

Terns Clinical Study Site 1013, San Diego

92117

Terns Clinical Study Site 1004, Coronado

92377

Terns Clinical Study Site 1040, Rialto

All Listed Sponsors
lead

Terns, Inc.

INDUSTRY